Filing Flows › Inovio Pharmaceuticals (INO) › Q4 2024 › vs Q4 2023
Inovio Pharmaceuticals (INO) Q4 2024 vs Q4 2023 (year over year)
Inovio Pharmaceuticals's revenue rose $14K (+14%) from $103K in Q4 2023 to $117K in Q4 2024.
Inovio Pharmaceuticals, Q4 2024: revenue $117K (+14% year over year), net loss $19.4M, operating cash flow −$19.7M. The chart draws each line against Q4 2023, the increases inside each band.
Every line
| Line | Q4 2024 | Q4 2023 | Change | % |
|---|---|---|---|---|
| Revenue | $117K | $103K | $14K | +14% |
| Other income, net | $988K | $2.4M | −$1.4M | -59% |
| Net loss | $19.4M | $25.0M | −$5.6M | -22% |
| Costs & expenses | $20.5M | $27.5M | −$7.0M | -25% |
| Operating costs | $20.5M | $27.5M | −$7.0M | -25% |
| Research & development | $12.9M | $17.3M | −$4.4M | -25% |
| General & admin | $7.6M | $10.2M | −$2.6M | -26% |
| Operating cash sources | $21.4M | $29.1M | −$7.7M | -27% |
| Depreciation & amortization | $417K | $570K | −$153K | -27% |
| Share-based compensation | $1.3M | $2.3M | −$951K | -42% |
| Cash used in operations | $19.7M | $26.3M | −$6.6M | -25% |
| Net loss absorbed | $19.4M | $25.0M | −$5.6M | -22% |
| Working capital & other | $2.0M | $4.1M | −$2.1M | -51% |
Questions
How much did Inovio Pharmaceuticals's revenue grow year over year in Q4 2024?
Inovio Pharmaceuticals's revenue rose $14K (+14%) from $103K in Q4 2023 to $117K in Q4 2024.